IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-77

  1. 17,528 Posts.
    lightbulb Created with Sketch. 422
    As Ive said since they 've made the release yesterday I would think there is nothing immediate that the directors would know which would preclude them from buying on market ie a window may be open.

    Lets see if any updates over next few days
    But then again why would they need too if the AGM resolutions pass to give them free ones.

    I wonder if Tattarang are ever proactive in their investments ? - they did take more @ $1.30 placement ( halved that part at one stage today )
    Where have 51 capital gone with their updates ?

    Yep Im grumpy ( and sometimes others of the seven dwarfs)
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.335M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $2.546K 35.86K

Buyers (Bids)

No. Vol. Price($)
1 14158 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 14.37pm 31/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.